The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Schizophrenia Clinical Trial

Official title:

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01377896
• Other study ID #: NIS-NZA-XXX-2011/1
• Status: Completed
• Phase: N/A
• First received: June 14, 2011
• Last updated: June 27, 2011
• Start date: July 2010
• Est. completion date: October 2010

Study information

• Verified date: June 2011
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: South Africa: Human Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 221
• Est. completion date: October 2010
• Est. primary completion date: October 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients diagnosed with one of the following conditions: Schizophrenia, Bipolar disorders and Major depressive disorders.

Exclusion Criteria:

• Patients who have not been diagnosed with the conditions as outlined in the Inclusion criteria.

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Bipolar Disorder
• Bipolar Disorders
• Depression
• Depressive Disorder
• Depressive Disorder, Major
• Disease
• Major Depressive Disorders
• Schizophrenia

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca